Citation Impact
Citing Papers
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence
2018
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
2016
Works of Matthew Lucci being referenced
Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients
2015